Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 9, 2013, Pages

  David Knight, W ^a   Saxena, Ashwini ^b   Shell, Brent ^b   Prashant Nedungadi, T ^b   Mifflin, Steven W ^b   Cunningham, J Thomas ^b  

^a CHRISTOPHER NEWPORT UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Angiotensin; Blood pressure; Hypertension; Sleep apnea

Indexed keywords

LOSARTAN; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; OSMOTIC PUMP; PREOPTIC NUCLEUS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOLITARY TRACT NUCLEUS; TELEMETRY; THALAMUS VENTRAL NUCLEUS; TRANSCRIPTION INITIATION;

ANGIOTENSIN; BLOOD PRESSURE; HYPERTENSION; SLEEP APNEA;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANOXIA; ARTERIAL PRESSURE; AUTONOMIC NERVOUS SYSTEM; BRAIN; CHRONIC DISEASE; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HYPERTENSION; INFUSIONS, INTRAVENTRICULAR; INFUSIONS, SUBCUTANEOUS; LOSARTAN; MALE; PHOTOPERIOD; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84887011641     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00541.2012     Document Type: Article

References (52)

1. Allen AM. Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J Physiol 510: 773-781, 1998.
2. Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens 13: 31S-38S, 2000.
3. Bohlender J, Imboden H. Angiotensinergic neurotransmission in the peripheral autonomic nervous system. Front Biosci 17: 2419-2432, 2012.
4. Bourassa EA, Sved AF, Speth RC. Angiotensin modulation of rostral ventrolateral medulla (RVLM) in cardiovascular regulation. Mol Cell Endocrinol 302: 167-175, 2009.
5. Brody MJ, Fink GD, Buggy J, Haywood JR, Gordon FJ, Johnson AK. The role of the anteroventral third ventricle (AV3V) region in experimental hypertension. Circ Res 43: I2-I13, 1978.
6. Brooks VL. Interactions between angiotensin II and the sympathetic nervous system in the long-term control of arterial pressure. Clin Exp Pharmacol Physiol 24: 83-90, 1997.
7. Chen D, Bassi JK, Walther T, Thomas WG, Allen AM. Expression of angiotensin type 1A receptors in C1 neurons restores the sympathoexci-tation to angiotensin in the rostral ventrolateral medulla of angiotensin type 1A knockout mice. Hypertension 56: 143-150, 2010.
8. Collister JP, Hendel MD. Chronic effects of angiotensin II and at1 receptor antagonists in subfornical organ-lesioned rats. Clin Exp Pharmacol Physiol 32: 462-466, 2005.
9. Cunningham JT, Knight WD, Mifflin SW, Nestler EJ. An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. Hypertension 60: 179-187, 2012.
10. Curtis KS, Cunningham JT, Heesch CM. Fos expression in brain stem nuclei of pregnant rats after hydralazine-induced hypotension. Am J Physiol Regul Integr Comp Physiol 277: R532-R540, 1999.
11. da Silva AQ, Fontes MA, Kanagy NL. Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea. Brain Res 1368: 231-238, 2011.
12. Dampney RA, Tan PS, Sheriff MJ, Fontes MA, Horiuchi J. Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep 9: 222-227, 2007.
13. Dendorfer A, Thornagel A, Raasch W, Grisk O, Tempel K, Dominiak P. Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 40: 348-354, 2002.
14. Diz DI, Garcia-Espinosa MA, Gegick S, Tommasi EN, Ferrario CM, Ann Tallant E, Chappell MC, Gallagher PE. Injections of angiotensinconverting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Exp Physiol 93: 694-700, 2008.
15. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34: 309-314, 1999.
16. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72: 1978-1984, 1992.
17. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
18. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92: 627-633, 2002.
19. Gehlert DR, Speth RC, Wamsley JK. Autoradiographic localization of angiotensin II receptors in the rat brain and kidney. Eur J Pharmacol 98: 145-146, 1984.
20. Howe BM, Bruno SB, Higgs KA, Stigers RL, Cunningham JT. FosB expression in the central nervous system following isotonic volume expansion in unanesthetized rats. Exp Neurol 187: 190-198, 2004.
21. Ito S, Sved AF. Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am J Physiol Regul Integr Comp Physiol 270: R1317-R1323, 1996.
22. Knight WD, Little JT, Carreno FR, Toney GM, Mifflin SW, Cunningham JT. Chronic intermittent hypoxia increases blood pressure and expression of FosB/-FosB in central autonomic regions. Am J Physiol Regul Integr Comp Physiol 301: R131-R139, 2011.
23. Lai CJ, Yang CC, Hsu YY, Lin YN, Kuo TB. Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol 100: 1974-1982, 2006.
24. Lesske J, Fletcher EC, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia-influence of chemoreceptors and sympathetic nervous system. J Hypertens 15: 1593-1603, 1997.
25. Li Z, Bains JS, Ferguson AV. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res Bull 30: 33-39, 1993.
26. Lin M, Liu R, Gozal D, Wead WB, Chapleau MW, Wurster R, Cheng Z. Chronic intermittent hypoxia impairs baroreflex control of heart rate but enhances heart rate responses to vagal efferent stimulation in anesthetized mice. Am J Physiol Heart Circ Physiol 293: H997-H1006, 2007.
27. Ma X, Bielefeldt K, Tan ZY, Whiteis CA, Snitsarev V, Abboud FM, Chapleau MW. Dual mechanisms of angiotensin-induced activation of mouse sympathetic neurones. J Physiol 573: 45-63, 2006.
28. Marcus NJ, Li YL, Bird CE, Schultz HD, Morgan BJ. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir Physiol Neurobiol 171: 36-45, 2010.
29. Marcus NJ, Philippi NR, Bird CE, Li YL, Schultz HD, Morgan BJ. Effect of AT 1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction. Respir Physiol Neurobiol 183: 67-74, 2012.
30. McKinley MJ, Gerstberger R, Mathai ML, Oldfield BJ, Schmid H. The lamina terminalis and its role in fluid and electrolyte homeostasis. J Clin Neurosci 6: 289-301, 1999.
31. Nestler EJ, Barrot M, Self DW. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci USA 98: 11042-11046, 2001.
32. Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med (Berl) 86: 705-710, 2008.
33. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.
34. Pediconi D, Martarelli D, Fontanazza A, Pompei P. Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels. Eur J Pharmacol 528: 79-87, 2005.
35. Penny ML, Bruno SB, Cornelius J, Higgs KA, Cunningham JT. The effects of osmotic stimulation and water availability on c-Fos and FosB staining in the supraoptic and paraventricular nuclei of the hypothalamus. Exp Neurol 194: 191-202, 2005.
36. Ployngam T, Collister JP. Role of the median preoptic nucleus in chronic angiotensin II-induced hypertension. Brain Res 1238: 75-84, 2008.
37. Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats. Eur J Pharmacol 307: 259-267, 1996.
38. Porter JP, Phillips A, Rich J, Wright D. Effect of chronic stress on the cardiac baroreflex in the post-weanling rat. Life Sci 75: 1595-1607, 2004.
39. Saper CB. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci 25: 433-469, 2002.
40. Silva AQ, Schreihofer AM. Altered sympathetic reflexes and vascular reactivity in rats after exposure to chronic intermittent hypoxia. J Physiol 589: 1463-1476, 2011.
41. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299: R405-R415, 2010.
42. Stocker SD, Cunningham JT, Toney GM. Water deprivation increases Fos immunoreactivity in PVN autonomic neurons with projections to the spinal cord and rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol 287: R1172-R1183, 2004.
43. Sullivan MJ, Hasser EM, Moffitt JA, Bruno SB, Cunningham JT. Rats exhibit aldosterone-dependent sodium appetite during 24 h hindlimb unloading. J Physiol 557: 661-670, 2004.
44. Tan PS, Killinger S, Horiuchi J, Dampney RA. Baroreceptor reflex modulation by circulating angiotensin II is mediated by AT1 receptors in the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 293: R2267-R2278, 2007.
45. Vialou V, Robison AJ, Laplant QC, Covington HE 3rd, Dietz DM, Ohnishi YN, Mouzon E, Rush AJ 3rd, Watts EL, Wallace DL, Iñiguez SD, Ohnishi YH, Steiner MA, Warren BL, Krishnan V, Bolaños CA, Neve RL, Ghose S, Berton O, Tamminga CA, Nestler EJ. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 13: 745-752, 2010.
46. Vieira AA, Nahey DB, Collister JP. Role of the organum vasculosum of the lamina terminalis for the chronic cardiovascular effects produced by endogenous and exogenous ANG II in conscious rats. Am J Physiol Regul Integr Comp Physiol 299: R1564-R1571, 2010.
47. Watson RE, Wiegland SJ, Clough RW, Hoffman GE. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7: 155-159, 1986.
48. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296: H1425-H1433, 2009.
49. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52: 679-686, 2008.
50. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 108: 9-12, 2003.
51. Zhuo J, Song K, Abdelrahman A, Mendelsohn FA. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 21: 557-567, 1994.
52. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.